ExtendicarePMZ receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Extendicare Inc (EXE)
Track today's live Extendicare Inc (EXE) share price, performance and key data on this page with our current Toronto:EXE stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Extendicare Inc share price on the Toronto exchange. Use the dropdown to switch exchange for the EXE share price, head to our technical summary section, which provides analysis on Extendicare Inc share price buy/sell indicators using real-time data (or discuss the Extendicare Inc (EXE) stock price today with other investors in the Extendicare Inc TSX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current TSX:EXE share price (ISIN: CA30224T8639) to enhance your trading decisions with our free investment tools and resources.
What Is the Extendicare Inc Share Price Today?
The Extendicare Inc share price today is 32.16.
What Is the Stock Symbol for Extendicare Inc
The stock symbol (or 'ticker') for Extendicare Inc is "EXE."
What Stock Exchange Does Extendicare Inc Trade On?
Extendicare Inc is listed and trades on the Toronto stock exchange.
Is Extendicare Inc a Good Stock to Buy?
Determining whether Extendicare Inc (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current TSX:EXE share price (ISIN: CA30224T8639) to enhance your trading decisions with our free investment tools and resources.
What Is the Extendicare Inc Share Price Today?
The Extendicare Inc share price today is 32.16.
What Is the Stock Symbol for Extendicare Inc
The stock symbol (or 'ticker') for Extendicare Inc is "EXE."
What Stock Exchange Does Extendicare Inc Trade On?
Extendicare Inc is listed and trades on the Toronto stock exchange.
Is Extendicare Inc a Good Stock to Buy?
Determining whether Extendicare Inc (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
32.16
-0.58(-1.77%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
32.01
33.38
52 wk Range
12.64
39.14
EXE is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
32.0133.38
52 wk Range
12.6439.14
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.62%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.62%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EXE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
39.83
Upside
+23.86%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Short term obligations exceed liquid assets
ExtendicarePMZ receives Investment Bank Analyst Rating Update- Investing.com
Pro
- ExtendicarePMZ receives Investment Bank Analyst Rating Update
- Investing.com
Pro - ExtendicarePMZ receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 39.83
(+23.86% Upside)
Extendicare Inc Earnings Call Summary for Q2/2026
- Extendicare Q2 2026 revenue surged 59.4% YoY to CAD 611M, beating estimates by 22.6%, driven by CBI acquisition and organic growth.
- EPS of $0.319 missed consensus of $0.34 by 6.2%; shares fell 8.7% as integration costs and higher spending pressured margins.
- Adjusted EBITDA rose 71.7% to CAD 68.3M; management says back-office investment phase largely complete, no major headcount additions planned.
- CBI integration to take 18-24 months with CAD 7.4M synergies expected; five new long-term care homes opening next four quarters.
- Management projects home healthcare margins to improve 50-100 bps over time; long-term growth to normalize at 6-8% annually post-integration.
Last Updated: 07/08/2026, 17:50
Read Full TranscriptEarnings
Latest Release
06/08/2026
EPS / Forecast
0.32 / 0.34
Revenue / Forecast
611.04M / 498.3M
Compare EXE to Peers and Sector
Metrics to compare | EXE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEXEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 25.7x | 12.1x | −0.4x | |
PEG Ratio | 0.69 | 0.10 | 0.00 | |
Price/Book | 7.7x | 1.3x | 2.6x | |
Price / LTM Sales | 1.6x | 0.9x | 3.1x | |
Upside (Analyst Target) | 19.1% | 27.6% | 47.9% | |
Fair Value Upside | Unlock | 14.6% | 6.3% | Unlock |
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. It operates through the Long-term Care, Home Health Care, and Managed Services segments. The company offers long-term care services, such as accommodation and meals, and assistance with activities of daily living and continuing care to residents; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties and joint ventures. It provides its services under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. The company was incorporated in 1968 and is based in Markham, Canada.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Extendicare Inc (Toronto: EXE) Share Price Today?
The Extendicare Inc stock price today is 32.16 CAD.
What Stock Exchange Does Extendicare Inc (EXE) Trade On?
Extendicare Inc is listed and trades on the Toronto Stock Exchange.
What Is the Ticker (Stock Symbol) for Extendicare Inc?
The stock symbol (also called a 'ticker') for Extendicare Inc is "EXE."
Does Extendicare Inc Pay Dividends? What’s The Current EXE Dividend Yield?
Yes, EXE Pays Dividends to its Shareholders. The current Extendicare Inc dividend yield is 1.62%.
What Is the Current Extendicare Inc Market Capitalisation?
As of today, Extendicare Inc (Toronto: EXE) market cap is 3.06B CAD.
What Is Extendicare Inc's (EXE) Earnings Per Share (TTM)?
The Extendicare Inc EPS is currently 1.31 (Trailing Twelve Months).
When Is the Next Extendicare Inc Earnings Date?
Extendicare Inc's next earnings report will be released on 05/11/2026.
Is EXE a Buy or Sell From a Technical Analyst Perspective?
Based on today's Extendicare Inc moving averages and other technical indicators, the daily buy/sell signal for EXE stock is Strong Sell.
How Many Times Has Extendicare Inc Stock Split?
Extendicare Inc has split 0 times. (See the EXE stock split history page for full effective split date and price information.)
How Many Employees Does Extendicare Inc Have?
Extendicare Inc has 23500 employees, based on their latest Companies House report.
What is the current trading status of Extendicare Inc (Toronto: EXE)?
As of 17/08/2026, Extendicare Inc (EXE) is trading at a share price of 32.16 CAD, with a previous close of 32.74 CAD. The stock has fluctuated within a day range of 32.01 CAD to 33.38 CAD, while its 52-week range spans from 12.64 CAD to 39.14 CAD.
What Is Extendicare Inc (EXE) Price Target According to Analysts?
The average 12-month price target for Extendicare Inc is 39.83 CAD, with a high estimate of 45 CAD and a low estimate of 31.5 CAD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +23.86% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.